Company intelligence / Profile preview
Doctor's Biome
Hauppauge, New York, United States
- Ownership
- Private
- Development stage
- Other
01
Overview
Doctor's Biome’s proprietary Signature Probiotic Blend has shown complete in vitro inhibition of major pathogenic bacteria (including C. difficile and epsilon toxin-producing C. perfringens). Their juice-based living probiotic has been studied for dietary management of multiple sclerosis and for inhibition of various pathogens linked to gut health and women's health[4][5][6]. All published results are currently preclinical/in vitro.
- Therapeutic areas
- Infectious DiseasesGastroenterologyNeurology
- Modalities
- Live biotherapeutic product therapyMicrobial therapy
- Industry
- Biotech
02
Drug pipeline
3 assets2 more assets in the full pipeline.
Request access →Beyond the preview
Go deeper on Doctor's Biome.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Doctor's Biome.